Literature DB >> 8706778

The anti-ulcer drug sucralfate does not affect gastric nicotine levels.

G Lindell1, H Graffner.   

Abstract

OBJECTIVE: It has been claimed that sucralfate can overcome the negative effects of nicotine in patients with peptic ulcer disease, although the possible mechanism being unknown. This study was performed in order to test whether sucralfate was capable of binding intragastric nicotine, thus making it impossible for the substance to exert effect.
METHOD: Nicotine was administered via transdermal patches or as capsules yielding gastric concentrations of 40-2980 ng.ml-1. Gastric juice aspirates (n = 9) were incubated with sucralfate, which was then separated by centrifugation, and the nicotine concentration was compared in incubated and non-incubated samples.
RESULTS: A median decrease of 13% (range 0-27%) in nicotine concentration was seen after incubation with sucralfate (P = 0.01).
CONCLUSION: The binding of nicotine to the precipitating agent sucralfate is not sufficient effectively to remove nicotine from the gastric juice.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8706778     DOI: 10.1007/BF00195939

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  12 in total

1.  The influence of chronic or acute nicotine pretreatment on ethanol-induced gastric ulceration in the rat.

Authors:  S H Wong; C W Ogle; C H Cho
Journal:  J Pharm Pharmacol       Date:  1986-07       Impact factor: 3.765

2.  Increased ulcer relapse rate after PCV in smokers.

Authors:  H Graffner; G Lindell
Journal:  World J Surg       Date:  1988-04       Impact factor: 3.352

3.  Influence of smoking on healing rate of duodenal ulcer in response to cimetidine or high-dose antacid.

Authors:  M G Korman; R G Shaw; J Hansky; G T Schmidt; A I Stern
Journal:  Gastroenterology       Date:  1981-06       Impact factor: 22.682

4.  Cimetidine, cigarette smoking, and recurrence of duodenal ulcer.

Authors:  S Sontag; D Y Graham; A Belsito; J Weiss; A Farley; R Grunt; N Cohen; D Kinnear; W Davis; A Archambault
Journal:  N Engl J Med       Date:  1984-09-13       Impact factor: 91.245

Review 5.  Implications of sucralfate-induced ulcer healing and relapse.

Authors:  S K Lam
Journal:  Am J Med       Date:  1989-06-09       Impact factor: 4.965

6.  Sympatho-adrenal system involved in the inhibitory effects of nicotine on the vagally stimulated gastric acid output and mucosal blood flow in rats.

Authors:  K Yokotani; Y Okuma; Y Osumi
Journal:  Eur J Pharmacol       Date:  1986-10-07       Impact factor: 4.432

7.  Acute effects of smoking during modified sham feeding in duodenal ulcer patients. An analysis of nicotine, acid secretion, gastrin, catecholamines, epidermal growth factor, prostaglandin E2, and bile acids.

Authors:  G Lindell; L O Farnebo; D Chen; E Nexø; J Rask Madsen; K Bukhave; H Graffner
Journal:  Scand J Gastroenterol       Date:  1993-06       Impact factor: 2.423

8.  The influence of acute or chronic nicotine treatment on ethanol-induced gastric mucosal damage in rats.

Authors:  C H Cho; B W Chen; W M Hui; S K Lam
Journal:  Dig Dis Sci       Date:  1990-01       Impact factor: 3.199

9.  Role of acid milieu in the gastroprotective and ulcer-healing activity of sucralfate.

Authors:  S J Konturek; T Brzozowski; D Drozdowicz; J Garlicki; J Majka; J Pytko-Polonczyk
Journal:  Am J Med       Date:  1991-08-08       Impact factor: 4.965

10.  Influence of cigarette smoking on healing and relapse in duodenal ulcer disease.

Authors:  M G Korman; J Hansky; E R Eaves; G T Schmidt
Journal:  Gastroenterology       Date:  1983-10       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.